caribou biosciences stock forecast
Caribou Biosciences CRBU-054. Caribou Biosciences Provides Business Update and Reports Second Quarter 2021 Financial Results Completed upsized initial public offering of common stock raising 3496 million in gross proceeds including full exercise of underwriters option to purchase additional shares 9 months ago - GlobeNewsWire.
Pin On Canada
Ad Biotech is becoming one of the best new sectors for investing if you know where to look.
. A high-level overview of Caribou Biosciences Inc. Stock price gained 735 on the last trading day Friday 17th Jun 2022 rising from 517 to 555. Rooms Shows Rankings Earnings Newsletters Shop.
The current Caribou Biosciences CRBU share price is 571. The average price target is 2780 with a high forecast of 3600 and a low forecast of 1900. Caribou Biosciences Double Exponential Smoothing.
The median estimate difference from the. According to 13 stock analysts the average 12-month stock price forecast for CRBU stock is 3002 which predicts an increase of 4409. Caribou Biosciences Inc CRBU Stock Earning Per Share EPS Forecast Estimate.
Volume 100-day 674549 Market Cap 530565117 Days Range 858 - 921 52-week Range 641 - 3265 Dividend Yield Ex. Revenue is forecast to grow 3304 per year Risk Analysis Earnings are forecast to decline by an average of 245 per year for the next 3 years Currently unprofitable and not forecast to become profitable over the next 3 years Volatile share price over the past 3 months See All Risk Checks Caribou Biosciences Competitors CRISPR Therapeutics. Their CRBU stock forecasts range from 1900 to 3900.
Modernas stock rose 28X in the past 2 years are these biotech picks next. 447p How big is the. According to the issued ratings of 8 analysts in the last year the consensus rating for Caribou Biosciences stock is Buy based on the current 8 buy ratings for CRBU.
Berkeley calif may 03 2022 globe newswire -- caribou biosciences inc. Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of. Dividend Date P-E EPS Earnings Date 080722.
CRBU stock forecast and price target Find the latest Caribou Biosciences Inc. The 10 analysts offering price forecasts for Caribou Biosciences have a median target of 3000 with a high estimate of 3900 and a low estimate of 2200. Analysis of Caribou Biosciences Double Exponential Smoothing Double exponential smoothing - also known as Holt exponential smoothing is a refinement of the popular simple exponentia.
During the day the stock fluctuated 967 from a day low at 517 to a day high of 567. Learn more about Earnings Per Share EPS. On average they predict Caribou Biosciences share price to reach 2971 in the next year.
Wainwright Thinks Caribou Biosciences Stock is Going to Recover June 13 2022 June 10 2022TipRanks Caribou Biosciences Reports Positive Additional Data. The average price target represents a 40000 change from the last price of 556. The lowest target is 1919 and the highest is 4095.
Based on 6 Wall Street analysts offering 12 month price targets for Caribou Biosciences in the last 3 months. 8 Wall Street research analysts have issued 12 month target prices for Caribou Biosciences stock. On average analysts rate CRBU stock as a buy.
Caribou Biosciences Inc. CRBU analyst stock forecast price target and recommendation trends with in-depth. On average analysts forecast that CRBUs EPS will be -154 for 2022 with the lowest EPS forecast at -180 and the highest EPS forecast at -139.
The Caribou Biosciences Inc. CARIBOU BIOSCIENCES INC Stock 794 -032 -387 Updated Apr 11 2022 1W - 1712 1M - 136 3M - 3869 CRBU Price 794 Fair Value Price 1193 Market Cap 48167M 52 Week Low 789 52 Week High 3265 PE -376x PB 124x PS NA PEG NA Dividend Yield NA Revenue 000 Earnings -6692M Gross Margin NA Operating Margin NA Profit Margin NA. Real-time trade and investing ideas on Caribou Biosciences Inc CRBU from the largest community of traders and investors.
Stock Price Forecast The 7 analysts offering 12-month price forecasts for Caribou Biosciences Inc have a median target of 2800 with a high estimate of 3900 and a low estimate of 1900. The price has been going up and down for this period and there has been a -365 loss for the last 2 weeks. CRBU CARIBOU BIOSCIENCESs current Earnings Per Share EPS is -208.
The average twelve-month price prediction for Caribou Biosciences is 2971 with a high price target of 3900 and a. Analyst estimates including CRBU earnings per share estimates and analyst recommendations. Will Caribou Biosciences Stock Go Up Next Year.
Crbu a leading clinical-stage crispr genome-editing biopharmaceutical company announced today that rachel. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. This suggests a possible upside of 4354 from the stocks current price.
Caribou Biosciences Inc CRBU Analyst Forecast CRBU Price Volume Earnings and Dividend Date Last Price 874 Previous Close 861 Change 013 Open 859 Volume 944453 Avg. The average consensus EPS for CRBU is -0372 with a high estimate of -0378 and Low of -0367 for the period 2022-03-31 and based on 5 Institutional Analysts. The Score for CRBU is 17 which is 66 below its historic median score of 50 and infers higher risk than normal.
CRBU is currently trading in the 10-20 percentile range relative to its historical Stock Score levels.
Gevo Inc Stock Holding Strong For Higher Levels Gevo Stock Global Economy Stock Market High Level
Pin On Projection Mapping
Pin On Quotes
Pin On Titanic
Pin On Fall Travel
Lily Of The Valley Lily Of The Valley Wallpaper Aesthetic Lily Of The Valley Aquarius And Cancer
Appletizer Scout Life Color Concept A W 2020 2021 Couleur Tendance Pantone Palette De Couleurs
Pin On Maison
Pin On Products
Genome Editing Market Size Share Trends And Forecast To 2023 Genome Marketing Cell Line
Pin On Images
Reindeer Toronto Zoo Reindeer Eurasia Torontozoo Wildlife Toronto Zoo Reindeer Cairngorms
50 Image Christian Collage Kit Soft Colors Collage Kit Wall Etsy Christian Friends Christian Color Collage
Anatomic Pathology Market Size And Forecast To 2022 Pathology Marketing Trends Anatomical